- Home
- BJDX vs XXII Comparison
BJDX vs XXII Comparison
Compare BJDX & XXII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BJDX | XXII |
|---|---|---|
| Founded | 2015 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Medicinal Chemicals and Botanical Products |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 865.6K | 949.6K |
| IPO Year | 2021 | 2011 |
Fundamental Metrics
Financial Performance| Metric | BJDX | XXII |
|---|---|---|
| Price | $0.83 | $0.81 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 333.6K | 187.5K |
| Earning Date | 11-06-2026 | 11-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 86.65 | 69.96 |
| EPS | ★ N/A | N/A |
| Revenue | $249,040.00 | ★ $25,832,530.00 |
| Revenue This Year | N/A | $361.06 |
| Revenue Next Year | N/A | $1,493.14 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.63 | $0.27 |
| 52 Week High | $7.00 | $11.37 |
Technical Indicators
Market Signals| Indicator | BJDX | XXII |
|---|---|---|
| Relative Strength Index (RSI) | 42.99 | 24.64 |
| Support Level | $0.82 | $0.73 |
| Resistance Level | $1.06 | $0.99 |
| Average True Range (ATR) | 0.06 | 0.24 |
| MACD | -0.00 | 0.03 |
| Stochastic Oscillator | 27.09 | 1.39 |
Price Performance
Historical ComparisonAbout BJDX Bluejay Diagnostics Inc.
Bluejay Diagnostics Inc is a medical diagnostics company focused on improving patient outcomes using its Symphony System, a cost-effective, rapid, near-patient testing system for sepsis triage and monitoring of disease progression. Bluejay's first product candidate, an IL-6 Test for sepsis, is designed to provide accurate, reliable results in approximately 20 minutes from sample-to-result to help medical professionals make earlier and quicker triage/treatment decisions.
About XXII 22nd Century Group Inc.
22nd Century Group Inc is a tobacco products company that enables cigarette smokers to take control of their consumption of nicotine, the addictive drug in cigarettes. The company manufactures and distributes the only combustible tobacco products containing minimally or non-addictive levels of nicotine. The Company has organized its business as a single reportable segment: tobacco, as it operates and derives all revenues from its tobacco operations and products.